CDC To Lead Data Accrual On Clinical Validity Of Genetic Tests
This article was originally published in The Gray Sheet
Executive Summary
The Centers for Disease Control and Prevention will establish a public/private consortium to recommend clinical validation and post-marketing data collection processes for predictive genetic disease tests.
You may also be interested in...
Genetic Testing Oversight Public Input Sought By HHS Advisory Panel
HHS' Advisory Committee on Genetic Testing will solicit public input at a Jan. 27 meeting to help determine an appropriate mechanism for the collection and analysis of data on the analytical validity, clinical validity and clinical utility of genetics tests, panel members agreed at their Oct. 26 meeting.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.